After half-century's wait, approval paves path for new lupus drugs

Abstract

400 volume 17 | number 4 | april 2011 nature medicine On 9 March, Benlysta (belimumab) became the first lupus drug approved by US regulators in over half a century. The event was cause for celebration, not only for Human Genome Sciences, the Rockville, Maryland biotechnology company that originally developed the drug, but also for its many competitors… (More)
DOI: 10.1038/nm0411-400a

Topics

  • Blog articles referencing this paper

  • Presentations referencing similar topics